Neopterin: A Promising Candidate Biomarker for Severe COVID-19

References

• JHU. Corona virus resource center. JHU; 2020. Available from: https://coronavirus.jhu.edu/. Accessed December 11, 2020.
   Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatrica. 2020;109(6):1088–1095. doi:10.1111/apa.15270
   PubMed Web of Science ®Google Scholar
• Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020:1–8.
   PubMed Web of Science ®Google Scholar
• Webb BJ, Peltan ID, Jensen P, et al. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study. Lancet Rheumatol. 2020;2(12):e754–e763. doi:10.1016/S2665-9913(20)30343-X
   PubMedGoogle Scholar
• Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in diagnosis of COVID-19–A systematic review. Life Sci. 2020:117788.
   PubMed Web of Science ®Google Scholar
• Eisenhut M. Neopterin in diagnosis and monitoring of infectious diseases. J biomark. 2013;2013:1–10.
   Google Scholar
• Fuchs D, Avanzas P, Arroyo-Espliguero R, Jenny M, Consuegra-Sanchez L, Kaski J. The role of neopterin in atherogenesis and cardiovascular risk assessment. Curr Med Chem. 2009;16(35):4644–4653. doi:10.2174/092986709789878247
   PubMed Web of Science ®Google Scholar
• Murr C, Fuith L, Widner B, Wirleitner B, Baier-Bitterlich G, Fuchs D. Increased neopterin concentrations in patients with cancer: indicator of oxidative stress? Anticancer Res. 1999;19(3A):1721–1728.
   PubMed Web of Science ®Google Scholar
• Yadav AK, Sharma V, Jha V. Association between serum neopterin and inflammatory activation in chronic kidney disease. Mediators Inflamm. 2012;2012. doi:10.1155/2012/476979
   PubMed Web of Science ®Google Scholar
• Hoffmann G, Wirleitner B, Fuchs D. Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res. 2003;52(8):313–321. doi:10.1007/s00011-003-1181-9
   PubMed Web of Science ®Google Scholar
• Müller MM, Curtius H-C, Herold M, Huber CH. Neopterin in clinical practice. Clinica chimica acta. 1991;201(1–2):1–16.
   PubMed Web of Science ®Google Scholar
• Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Current Drug Metabolism. 2002;3(2):175–187. doi:10.2174/1389200024605082
   PubMed Web of Science ®Google Scholar
• Fuchs D, Weiss G, Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol. 1993;101(1):1–6. doi:10.1159/000236491
   PubMed Web of Science ®Google Scholar
• Huber C, Batchelor JR, Fuchs D, et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med. 1984;160(1):310–316. doi:10.1084/jem.160.1.310
   PubMed Web of Science ®Google Scholar
• Wirleitner B, Reider D, Ebner S, et al. Monocyte-derived dendritic cells release neopterin. J Leukocyte Biol. 2002;72(6):1148–1153.
   PubMed Web of Science ®Google Scholar
• Sghiri R, Feinberg J, Thabet F, et al. Gamma interferon is dispensable for neopterin production in vivo. Clin Diagn Lab Immunol. 2005;12(12):1437–1441. doi:10.1128/CDLI.12.12.1437-1441.2005
   PubMedGoogle Scholar
• Werner-Felmayer G, Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Characteristics of interferon induced tryptophan metabolism in human cells in vitro. Biochimica et Biophysica Acta. 1989;1012(2):140–147. doi:10.1016/0167-4889(89)90087-6
   PubMedGoogle Scholar
• Terness P, Bauer TM, Rose L, et al. Inhibition of allogeneic T cell proliferation by indoleamine 2, 3-dioxygenase–expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med. 2002;196(4):447–457. doi:10.1084/jem.20020052
   PubMed Web of Science ®Google Scholar
• Hol JW, Stolker RJ, Klimek M, Stronks DL, Fekkes D. The tryptophan kynurenine pathway, neopterin and IL-6 during vulvectomy and abdominal hysterectomy. J Biomed Sci. 2014;21(1):102. doi:10.1186/s12929-014-0102-2
   PubMedGoogle Scholar
• Widner B, Leblhuber F, Fuchs D. Increased neopterin production and tryptophan degradation in advanced Parkinson’s disease. J Neural Transm. 2002;109(2):181–189. doi:10.1007/s007020200014
   PubMed Web of Science ®Google Scholar
• Fuchs D, Möller AA, Reibnegger G, et al. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunol Letters. 1991;28(3):207–211. doi:10.1016/0165-2478(91)90005-u
   PubMed Web of Science ®Google Scholar
• Svoboda P, Ko S-H, Cho B, et al. Neopterin, a marker of immune response, and 8-hydroxy-2′-deoxyguanosine, a marker of oxidative stress, correlate at high age as determined by automated simultaneous high-performance liquid chromatography analysis of human urine. Anal Biochem. 2008;383(2):236–242. doi:10.1016/j.ab.2008.09.014
   PubMed Web of Science ®Google Scholar
• Toygar M, Aydin I, Agilli M, et al. The relation between oxidative stress, inflammation, and neopterin in the paraquat-induced lung toxicity. Hum Exp Toxicol. 2014;34(2):198–204. doi:10.1177/0960327114533808
   PubMed Web of Science ®Google Scholar
• Schobersberger W, Hoffmann G, Grote J, Wachter H, Fuchs D. Induction of inducible nitric oxide synthase expression by neopterin in vascular smooth muscle cells. FEBS Lett. 1995;377(3):461–464.
   PubMed Web of Science ®Google Scholar
• Berdowska A, Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J Clin Pharm Ther. 2001;26(5):319–329. doi:10.1046/j.1365-2710.2001.00358.x
   PubMed Web of Science ®Google Scholar
• Plata-Nazar K, Jankowska A. Clinical usefulness of determining the concentration of neopterin. Pteridines. 2011;22(1):77. doi:10.1515/pteridines.2011.22.1.77
   Google Scholar
• Müller MM, Curtius H-C, Herold M, Huber CH. Neopterin in clinical practice. Clinica Chimica Acta. 1991;201(1):1–16.
   PubMed Web of Science ®Google Scholar
• Firth CA, Laing AD, Baird SK, Pearson J, Gieseg SP. Inflammatory sites as a source of plasma neopterin: measurement of high levels of neopterin and markers of oxidative stress in pus drained from human abscesses. Clin Biochem. 2008;41(13):1078–1083. doi:10.1016/j.clinbiochem.2008.06.008
   PubMed Web of Science ®Google Scholar
• Chan CPY, Choi JWY, Cao K-Y, et al. Detection of serum neopterin for early assessment of dengue virus infection. J Infect. 2006;53(3):152–158. doi:10.1016/j.jinf.2005.11.008
   PubMed Web of Science ®Google Scholar
• Kalkan A, Ozden M, Akbulut H. Serum neopterin levels in patients with chronic hepatitis B. Jpn J Infect Dis. 2005;58(2):107–109.
   PubMed Web of Science ®Google Scholar
• Pizzini A, Kurz K, Santifaller J, et al. Assessment of neopterin and indoleamine 2,3-dioxygenase activity in patients with seasonal influenza: a pilot study. Influenza Other Respir Viruses. 2019;13(6):603–609. doi:10.1111/irv.12677
   PubMed Web of Science ®Google Scholar
• Onguru P, Akgul EO, Akıncı E, et al. High serum levels of neopterin in patients with Crimean–Congo hemorrhagic fever and its relation with mortality. J Infect. 2008;56(5):366–370. doi:10.1016/j.jinf.2008.03.006
   PubMed Web of Science ®Google Scholar
• Mildvan D, Spritzler J, Grossberg SE, et al. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection. Clin Infect Dis. 2005;40(6):853–858. doi:10.1086/427877
   PubMed Web of Science ®Google Scholar
• Wirleitner B, Schroecksnadel K, Winkler C, Fuchs D. Neopterin in HIV-1 infection. Mol Immunol. 2005;42(2):183–194. doi:10.1016/j.molimm.2004.06.017
   PubMed Web of Science ®Google Scholar
• Eisenhut M. Neopterin in diagnosis and monitoring of infectious diseases. J Biomark. 2013;2013:196432.
   PubMedGoogle Scholar
• Pacileo M, Cirillo P, De Rosa S, et al. The role of neopterin in cardiovascular disease. Monaldi Arch Chest Dis. 2007;68(2):68–73. doi:10.4081/monaldi.2007.454
   PubMedGoogle Scholar
• Sucher R, Schroecksnadel K, Weiss G, Margreiter R, Fuchs D, Brandacher G. Neopterin, a prognostic marker in human malignancies. Cancer Lett. 2010;287(1):13–22. doi:10.1016/j.canlet.2009.05.008
   PubMed Web of Science ®Google Scholar
• Melichar B, Spisarová M, Bartoušková M, Krčmová LK, Javorská L, Študentová H. Neopterin as a biomarker of immune response in cancer patients. Ann Transl Med. 2017;5(13):280. doi:10.21037/atm.2017.06.29
   PubMed Web of Science ®Google Scholar
• Braciale TJ, Hahn YS. Immunity to viruses. Immunol Rev. 2013;255(1):5–12. doi:10.1111/imr.12109
   PubMed Web of Science ®Google Scholar
• Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 cytokine storm; what we know so far. Front Immunol. 2020;11:1446. doi:10.3389/fimmu.2020.01446
   PubMed Web of Science ®Google Scholar
• Wang C, Xie J, Zhao L, et al. Aveolar macrophage activation and cytokine storm in the pathogenesis of severe COVID-19. Research Square; 2020.
   Google Scholar
• Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: lessons from SARS and MERS, and potential therapeutic interventions. Life Sci. 2020:118102.
   PubMed Web of Science ®Google Scholar
• Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres FJI. Role of monocytes/macrophages in covid-19 pathogenesis: implications for therapy. Infect Drug Resist. 2020;13:2485. doi:10.2147/IDR.S258639
   PubMed Web of Science ®Google Scholar
• Ravelli A. Macrophage activation syndrome. Curr Opinion Rheumatol. 2002;14(5):548–552. doi:10.1097/00002281-200209000-00012
   PubMed Web of Science ®Google Scholar
• Lerkvaleekul B, Vilaiyuk S. Macrophage activation syndrome: early diagnosis is key. Open Access Rheumatol: Res Rev. 2018;10:117. doi:10.2147/OARRR.S151013
   PubMed Web of Science ®Google Scholar
• McGonagle D, Sharif K, O’Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev. 2020;19(6):102537. doi:10.1016/j.autrev.2020.102537
   PubMed Web of Science ®Google Scholar
• Forrest CM, Youd P, Kennedy A, Gould SR, Darlington LG, Stone TW. Purine, kynurenine, neopterin and lipid peroxidation levels in inflammatory bowel disease. J Biomed Sci. 2002;9(5):436–442. doi:10.1007/BF02256538
   PubMed Web of Science ®Google Scholar
• Carvelli J, Demaria O, Vély F, et al. Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis. Nature. 2020:1–5.
   Web of Science ®Google Scholar
• Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LF. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev. 2020:1–12.
   Google Scholar
• Feng X, Li S, Sun Q, et al. Immune-inflammatory parameters in COVID-19 cases: a systematic review and meta-analysis. Front Med. 2020;7(301).
   Google Scholar
• Zeng F, Huang Y, Guo Y, et al. Association of inflammatory markers with the severity of COVID-19: a meta-analysis. Int J Infect Dis. 2020.
   Web of Science ®Google Scholar
• Senanayake SL Drug repurposing strategies for COVID-19. Future Science; 2020.
   Google Scholar
• Park M, Thwaites RS, Openshaw PJ. COVID-19: lessons from SARS and MERS. Eur J Immunol. 2020;50(3):308.
   Web of Science ®Google Scholar
• Zheng B, Cao K-Y, Chan CP, et al. Serum neopterin for early assessment of severity of severe acute respiratory syndrome. Clin Immunol. 2005;116(1):18–26. doi:10.1016/j.clim.2005.03.009
   PubMed Web of Science ®Google Scholar
• Robertson J, Gostner JM, Nilsson S, Andersson L-M, Fuchs D, Gisslen M. Serum neopterin levels in relation to mild and severe COVID-19. medRxiv. 2020. doi:10.1101/2020.08.13.20147595
   Google Scholar
• Ozger HS, Dizbay M, Corbacioglu SK, et al. The prognostic role of neopterin in COVID-19 patients. J Med Virol. 2020.
   PubMedGoogle Scholar
• Edén A, Kanberg N, Gostner J, et al. CSF biomarkers in patients with COVID-19 and neurological symptoms: a case series. Neurology. 2020. doi:10.1212/WNL.0000000000010977
   PubMedGoogle Scholar
• Bellmann-Weiler R, Lanser L, Burkert F, et al. Neopterin predicts disease severity in hospitalized patients with COVID-19. Open Forum Infect Dis. 2020. doi:10.1093/ofid/ofaa521
   PubMed Web of Science ®Google Scholar